The study of common, complex phenotypes is confounded by the heterogeneity caused by multiple gene-gene and gene-environment interactions.
This challenge makes studying Alzheimer's disease a fascinating and rewarding research project, as it holds the potential of identifying druggable gene targets and genetic variants that could be used for early disease detection and prevention of this devastating neurodegenerative disease, which currently affects approximately 5 million Americans.